Market Insights Health Pharmacies OTC Products

Sleep Aids (Pharmacies) - EU-27

EU-27

Revenue in the Sleep Aids market is projected to reach US$1.11bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 2.18%, resulting in a market volume of US$1.21bn by 2028.
In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
In relation to total population figures, per person revenues of US$2.48 are generated in 2024.

Key regions: South Korea, Japan, Canada, France, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Sleep Aids (Pharmacies) market in EU-27 is experiencing steady growth due to increasing customer preferences for sleep aids, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in EU-27 are increasingly turning to sleep aids to address their sleep-related issues. The fast-paced and stressful lifestyles of individuals in this region have led to an increase in sleep disorders and insomnia. As a result, there is a growing demand for sleep aids that can help people fall asleep faster and improve the quality of their sleep.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in EU-27 is the rising popularity of natural and herbal sleep aids. Customers are becoming more conscious about the potential side effects of synthetic sleep aids and are seeking natural alternatives. This trend is driven by the growing interest in holistic health and wellness, as well as the perception that natural sleep aids are safer and have fewer side effects. Another trend in the market is the increasing availability of sleep aids without a prescription. This has made it easier for customers to access sleep aids and has contributed to the growth of the market. Pharmacies and online retailers are offering a wide range of over-the-counter sleep aids, making them more accessible to customers who prefer self-medication.

Local special circumstances: In EU-27, there are varying regulations and restrictions on the sale of sleep aids. Some countries have stricter regulations and require a prescription for certain sleep aids, while others allow over-the-counter sales. These local regulations and restrictions can influence the availability and accessibility of sleep aids in different countries within EU-27.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in EU-27 is also influenced by underlying macroeconomic factors. The increasing prevalence of sleep disorders and insomnia is driven by factors such as work-related stress, lifestyle changes, and aging populations. Additionally, the growing awareness and acceptance of mental health issues in society have also contributed to the demand for sleep aids. Furthermore, the healthcare expenditure in EU-27 countries is increasing, which has led to improved healthcare infrastructure and access to healthcare services. This has also contributed to the growth of the Sleep Aids (Pharmacies) market as more individuals are seeking professional help for their sleep-related issues. In conclusion, the Sleep Aids (Pharmacies) market in EU-27 is experiencing growth due to increasing customer preferences for sleep aids, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for sleep aids is driven by the need to address sleep disorders and insomnia caused by stressful lifestyles. The market is also influenced by trends towards natural and herbal sleep aids, as well as the availability of over-the-counter options. Local regulations and restrictions on the sale of sleep aids vary across EU-27 countries, affecting the accessibility and availability of these products. The underlying macroeconomic factors such as work-related stress, lifestyle changes, aging populations, and increased healthcare expenditure also contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.